Literature DB >> 22207131

Dynamic regulation of Th17 differentiation by oxygen concentrations.

Ai Ikejiri1, Shigenori Nagai, Nobuhito Goda, Yutaka Kurebayashi, Mayuko Osada-Oka, Keiyo Takubo, Toshio Suda, Shigeo Koyasu.   

Abstract

Naive CD4(+) T cells are activated by antigen-presenting cells (APCs) and differentiate into distinct types of helper T (T(h)) cells in the lymph node or spleen. Oxygen (O(2)) tension is generally low in these secondary lymphoid tissues compared with the bloodstream or atmosphere. However, the effect of changes in O(2) concentration on the differentiation of T(h) cells remains unclear. Here, we established a novel model of T(h)-cell differentiation, which mimics physiological O(2) conditions. We primed naive CD4(+) T cells under 5% O(2), which has been observed in the lymph node or spleen and reoxygenated under normoxia that mimicked the O(2) concentration in blood. In this model, the differentiation of T(h)17 cells, but not T(h)1 or iTreg cells, was enhanced. Under the condition of 5% O(2), mammalian target of rapamycin complex 1 (mTORC1) was activated and led to the stabilization of hypoxia-inducible factor 1α (HIF-1α) in T(h)17 cells. The activation of mTORC1 and the acceleration of T(h)17-cell differentiation, which occurred when cells were primed under 5% O(2), were not observed in the absence of HIF-1α but were accelerated in the absence of von Hippel-Lindau tumor suppressor protein (vHL), a factor critical for HIF-1α degradation. Thus, a positive feedback loop between HIF-1α and mTORC1 induced by hypoxia followed by reoxygenation accelerates T(h)17-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207131     DOI: 10.1093/intimm/dxr111

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  35 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Hypoxia-inducible factors regulate T cell metabolism and function.

Authors:  Anthony T Phan; Ananda W Goldrath
Journal:  Mol Immunol       Date:  2015-08-19       Impact factor: 4.407

3.  Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.

Authors:  Michihito Kono; Nobuya Yoshida; Kayaho Maeda; Abel Suárez-Fueyo; Vasileios C Kyttaris; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2019-09-27       Impact factor: 10.995

Review 4.  Metabolic control of the Treg/Th17 axis.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

5.  On the relationship between VDR, RORα and RORγ receptors expression and HIF1-α levels in human melanomas.

Authors:  Anna A Brożyna; Wojciech Jóźwicki; Anton M Jetten; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2019-08-08       Impact factor: 3.960

Review 6.  Hypoxia-inducible factors in T lymphocyte differentiation and function. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Jin-Hui Tao; Joseph Barbi; Fan Pan
Journal:  Am J Physiol Cell Physiol       Date:  2015-09-09       Impact factor: 4.249

Review 7.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

Review 8.  The obesity-related pathology and Th17 cells.

Authors:  Yusuke Endo; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Mol Life Sci       Date:  2016-10-18       Impact factor: 9.261

Review 9.  Integrating canonical and metabolic signalling programmes in the regulation of T cell responses.

Authors:  Kristen N Pollizzi; Jonathan D Powell
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

Review 10.  Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function.

Authors:  Eóin N McNamee; Darlynn Korns Johnson; Dirk Homann; Eric T Clambey
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.